{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:21:59Z","timestamp":1783952519197,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Innovation Projects in Shandong Province","award":["2018CXGC1204"],"award-info":[{"award-number":["2018CXGC1204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00930-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:26:29Z","timestamp":1777465589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chicoric acid targets PYGL to normalize glycogenolysis-driven glycolysis to suppress non-small cell lung cancer"],"prefix":"10.1186","volume":"31","author":[{"given":"Xingfa","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"930_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"930_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"key":"930_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"M-L Meyer","year":"2024","unstructured":"Meyer M-L, Fitzgerald BG, Paz-Ares L, Cappuzzo F, J\u00e4nne PA, Peters S, et\u00a0al. New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet. 2024;404:803\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(24)01029-8.","journal-title":"Lancet"},{"key":"930_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.annonc.2021.09.008","volume":"33","author":"JL Dickson","year":"2022","unstructured":"Dickson JL, Horst C, Nair A, Tisi S, Prendecki R, Janes SM. Hesitancy around low-dose CT screening for lung cancer. Ann Oncol. 2022;33:34\u201341. https:\/\/doi.org\/10.1016\/j.annonc.2021.09.008.","journal-title":"Ann Oncol"},{"key":"930_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","volume":"18","author":"P-L Su","year":"2025","unstructured":"Su P-L, Furuya N, Asrar A, Rolfo C, Li Z, Carbone DP, et\u00a0al. Recent advances in therapeutic strategies for non-small cell lung cancer. J Hematol Oncol. 2025;18:35. https:\/\/doi.org\/10.1186\/s13045-025-01679-1.","journal-title":"J Hematol Oncol"},{"key":"930_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27:1345\u201356. https:\/\/doi.org\/10.1038\/s41591-021-01450-2.","journal-title":"Nat Med"},{"key":"930_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","volume":"27","author":"I Vitale","year":"2021","unstructured":"Vitale I, Shema E, Loi S, Galluzzi L, Vitale I, Shema E. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med. 2021;27:212\u201324. https:\/\/doi.org\/10.1038\/s41591-021-01233-9.","journal-title":"Nat Med"},{"key":"930_CR8","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS, DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2:e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200.","journal-title":"Sci Adv"},{"key":"930_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168:657\u201369. https:\/\/doi.org\/10.1016\/j.cell.2016.12.039.","journal-title":"Cell"},{"key":"930_CR10","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ, Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473. https:\/\/doi.org\/10.1126\/science.aaw5473.","journal-title":"Science"},{"key":"930_CR11","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s42255-025-01243-8","volume":"7","author":"HA Clarke","year":"2025","unstructured":"Clarke HA, Hawkinson TR, Shedlock CJ, Medina T, Ribas RA, Wu L, et\u00a0al. Glycogen drives tumour initiation and progression in lung adenocarcinoma. Nat Metab. 2025;7:952\u201365. https:\/\/doi.org\/10.1038\/s42255-025-01243-8.","journal-title":"Nat Metab"},{"key":"930_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s42255-021-00367-x","volume":"3","author":"H Xie","year":"2021","unstructured":"Xie H, Song J, Godfrey J, Riscal R, Skuli N, Nissim I, et\u00a0al. Glycogen metabolism is dispensable for tumour progression in clear cell renal cell carcinoma. Nat Metab. 2021;3:327\u201336. https:\/\/doi.org\/10.1038\/s42255-021-00367-x.","journal-title":"Nat Metab"},{"key":"930_CR13","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","volume":"184","author":"Q Liu","year":"2021","unstructured":"Liu Q, Li J, Zhang W, Xiao C, Zhang S, Nian C, et\u00a0al. Glycogen accumulation and phase separation drives liver tumor initiation. Cell. 2021;184:5559-5576.e19. https:\/\/doi.org\/10.1016\/j.cell.2021.10.001.","journal-title":"Cell"},{"key":"930_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cmet.2012.10.017","volume":"16","author":"E Favaro","year":"2012","unstructured":"Favaro E, Bensaad K, Chong MG, Tennant DA, Ferguson DJP, Snell C, et\u00a0al. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. Cell Metab. 2012;16:751\u201364. https:\/\/doi.org\/10.1016\/j.cmet.2012.10.017.","journal-title":"Cell Metab"},{"key":"930_CR15","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.7150\/ijbs.76756","volume":"19","author":"Q Ji","year":"2023","unstructured":"Ji Q, Li H, Cai Z, Yuan X, Pu X, Huang Y, et\u00a0al. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. Int J Biol Sci. 2023;19:1894\u2013909. https:\/\/doi.org\/10.7150\/ijbs.76756.","journal-title":"Int J Biol Sci"},{"key":"930_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41419-022-05005-2","volume":"13","author":"CE Zois","year":"2022","unstructured":"Zois CE, Hendriks AM, Haider S, Pires E, Bridges E, Kalamida D, et\u00a0al. Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation. Cell Death Dis. 2022;13:573. https:\/\/doi.org\/10.1038\/s41419-022-05005-2.","journal-title":"Cell Death Dis"},{"key":"930_CR17","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41467-021-21853-6","volume":"12","author":"R Fu","year":"2021","unstructured":"Fu R, Zhang P, Jin G, Wang L, Qi S, Cao Y, et\u00a0al. Versatility in acyltransferase activity completes chicoric acid biosynthesis in purple coneflower. Nat Commun. 2021;12:1563. https:\/\/doi.org\/10.1038\/s41467-021-21853-6.","journal-title":"Nat Commun"},{"key":"930_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/tpj.16759","volume":"119","author":"G Jin","year":"2024","unstructured":"Jin G, Deng Z, Wang H, Zhang Y, Fu R. <scp>EpMYB2<\/scp> positively regulates chicoric acid biosynthesis by activating both primary and specialized metabolic genes in purple coneflower. Plant J. 2024;119:252\u201365. https:\/\/doi.org\/10.1111\/tpj.16759.","journal-title":"Plant J"},{"key":"930_CR19","doi-asserted-by":"publisher","first-page":"119814","DOI":"10.1007\/s11356-023-30742-y","volume":"30","author":"F Alharthi","year":"2023","unstructured":"Alharthi F. Chicoric acid enhances the antioxidative defense system and protects against inflammation and apoptosis associated with the colitis model induced by dextran sulfate sodium in rats. Environ Sci Pollut Res. 2023;30:119814\u201324. https:\/\/doi.org\/10.1007\/s11356-023-30742-y.","journal-title":"Environ Sci Pollut Res"},{"key":"930_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/bph.17354","author":"W Chen","year":"2024","unstructured":"Chen W, Shan Y, Wang M, Liang R, Sa R. Chicoric acid exerts therapeutic effects in DSS\u2010induced ulcerative colitis by targeting the USP9X\/IGF2BP2 axis. Br J Pharmacol. 2024. https:\/\/doi.org\/10.1111\/bph.17354.","journal-title":"Br J Pharmacol"},{"key":"930_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.intimp.2018.10.042","volume":"66","author":"H Ding","year":"2019","unstructured":"Ding H, Ci X, Cheng H, Yu Q, Li D. Chicoric acid alleviates lipopolysaccharide-induced acute lung injury in mice through anti-inflammatory and anti-oxidant activities. Int Immunopharmacol. 2019;66:169\u201376. https:\/\/doi.org\/10.1016\/j.intimp.2018.10.042.","journal-title":"Int Immunopharmacol"},{"key":"930_CR22","doi-asserted-by":"publisher","first-page":"e2400935","DOI":"10.1002\/ardp.202400935","volume":"358","author":"MI Fahmy","year":"2025","unstructured":"Fahmy MI, Elrayess RA, Althobaiti MM, Arab HH, Rashad A. Chicoric acid alleviates rotenone\u2010induced motor dysfunction in mice: targeting PI3K\/AKT\/caspase\u20103\u2010associated apoptosis and neuroinflammation. Arch Pharm (Weinheim). 2025;358:e2400935. https:\/\/doi.org\/10.1002\/ardp.202400935.","journal-title":"Arch Pharm (Weinheim)"},{"key":"930_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jchromb.2016.07.045","volume":"1031","author":"Y Wang","year":"2016","unstructured":"Wang Y, Xie G, Liu Q, Duan X, Liu Z, Liu X. Pharmacokinetics, tissue distribution, and plasma protein binding study of chicoric acid by HPLC\u2013MS\/MS. J Chromatogr B. 2016;1031:139\u201345. https:\/\/doi.org\/10.1016\/j.jchromb.2016.07.045.","journal-title":"J Chromatogr B"},{"key":"930_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics"},{"key":"930_CR25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/biom14070749","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J. TFTF: an R-Based integrative tool for decoding human transcription factor\u2013target interactions. Biomolecules. 2024;14:749. https:\/\/doi.org\/10.3390\/biom14070749.","journal-title":"Biomolecules"},{"key":"930_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-0716-3342-7_14","volume":"2693","author":"T Roychowdhury","year":"2024","unstructured":"Roychowdhury T, Santhaseela AR, Sharma S, Panchal P, Rodina A, Chiosis G. Use of Native-PAGE for the identification of epichaperomes in cell lines. Methods Mol Biol. 2024;2693:175\u201391. https:\/\/doi.org\/10.1007\/978-1-0716-3342-7_14.","journal-title":"Methods Mol Biol"},{"key":"930_CR27","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundb\u00e4ck T, Nordlund P, et\u00a0al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100\u201322. https:\/\/doi.org\/10.1038\/nprot.2014.138.","journal-title":"Nat Protoc"},{"key":"930_CR28","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021;61:3891\u20138. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203.","journal-title":"J Chem Inf Model"},{"key":"930_CR29","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan Y, Tao H, He J, Huang S-Y. The HDOCK server for integrated protein\u2013protein docking. Nat Protoc. 2020;15:1829\u201352. https:\/\/doi.org\/10.1038\/s41596-020-0312-x.","journal-title":"Nat Protoc"},{"key":"930_CR30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","volume":"11","author":"P Dey","year":"2021","unstructured":"Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discov. 2021;11:1067\u201381. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1211.","journal-title":"Cancer Discov"},{"key":"930_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/cac2.12359","volume":"42","author":"P Chen","year":"2022","unstructured":"Chen P, Liu Y, Wen Y, Zhou C. Non\u2010small cell lung cancer in China. Cancer Commun. 2022;42:937\u201370. https:\/\/doi.org\/10.1002\/cac2.12359.","journal-title":"Cancer Commun"},{"key":"930_CR32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cmet.2023.06.003","volume":"35","author":"W Zou","year":"2023","unstructured":"Zou W, Green DR. Beggars banquet: metabolism in the tumor immune microenvironment and cancer therapy. Cell Metab. 2023;35:1101\u201313. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.003.","journal-title":"Cell Metab"},{"key":"930_CR33","doi-asserted-by":"publisher","first-page":"101159","DOI":"10.1016\/j.drup.2024.101159","volume":"77","author":"S-H Lee","year":"2024","unstructured":"Lee S-H, Kim S, Lee J, Kim Y, Joo Y, Heo J, et\u00a0al. Comprehensive metabolomic analysis identifies key biomarkers and modulators of immunotherapy response in NSCLC patients. Drug Resist Updat. 2024;77:101159. https:\/\/doi.org\/10.1016\/j.drup.2024.101159.","journal-title":"Drug Resist Updat"},{"key":"930_CR34","doi-asserted-by":"publisher","unstructured":"Glycogen Accumulation Induces the Hippo Pathway and Liver Tumorigenesis. Cancer Discov. 2022;12:11. https:\/\/doi.org\/10.1158\/2159-8290.CD-RW2021-154","DOI":"10.1158\/2159-8290.CD-RW2021-154"},{"key":"930_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2021.02.009","volume":"504","author":"M Huang","year":"2021","unstructured":"Huang M, Zhou Y, Duan D, Yang C, Zhou Z, Li F, et\u00a0al. Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib. Cancer Lett. 2021;504:125\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.009.","journal-title":"Cancer Lett"},{"key":"930_CR36","doi-asserted-by":"publisher","first-page":"112358","DOI":"10.1016\/j.biopha.2021.112358","volume":"144","author":"S Prabhu Kirti","year":"2021","unstructured":"Prabhu Kirti S, Bhat AA, Siveen KS, Kuttikrishnan S, Raza SS, Raheed T, et\u00a0al. Sanguinarine mediated apoptosis in non-small cell lung cancer via generation of reactive oxygen species and suppression of JAK\/STAT pathway. Biomed Pharmacother. 2021;144:112358. https:\/\/doi.org\/10.1016\/j.biopha.2021.112358.","journal-title":"Biomed Pharmacother"},{"key":"930_CR37","doi-asserted-by":"publisher","first-page":"155175","DOI":"10.1016\/j.phymed.2023.155175","volume":"123","author":"H-J Sun","year":"2024","unstructured":"Sun H-J, Zheng G-L, Wang Z-C, Liu Y, Bao N, Xiao P-X, et\u00a0al. Chicoric acid ameliorates sepsis-induced cardiomyopathy via regulating macrophage metabolism reprogramming. Phytomedicine. 2024;123:155175. https:\/\/doi.org\/10.1016\/j.phymed.2023.155175.","journal-title":"Phytomedicine"},{"key":"930_CR38","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1074-5521(00)00004-1","volume":"7","author":"VL Rath","year":"2000","unstructured":"Rath VL, Ammirati M, Danley DE, Ekstrom JL, Gibbs EM, Hynes TR, et\u00a0al. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Chem Biol. 2000;7:677\u201382. https:\/\/doi.org\/10.1016\/S1074-5521(00)00004-1.","journal-title":"Chem Biol"},{"key":"930_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/10409238909082552","volume":"24","author":"CB Newgard","year":"1989","unstructured":"Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol. 1989;24:69\u201399. https:\/\/doi.org\/10.3109\/10409238909082552.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"930_CR40","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.apsb.2021.12.002","volume":"12","author":"H Tan","year":"2022","unstructured":"Tan H, Wang H, Ma J, Deng H, He Q, Chen Q, et\u00a0al. Identification of human LDHC4 as a potential target for anticancer drug discovery. Acta Pharm Sin B. 2022;12:2348\u201357. https:\/\/doi.org\/10.1016\/j.apsb.2021.12.002.","journal-title":"Acta Pharm Sin B"},{"key":"930_CR41","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1038\/s42255-022-00708-4","volume":"4","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang C, Zhang T, Chang C-Y, Wang J, Bazile L, et\u00a0al. Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer. Nat Metab. 2022;4:1830\u201346. https:\/\/doi.org\/10.1038\/s42255-022-00708-4.","journal-title":"Nat Metab"},{"key":"930_CR42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137","author":"J-C Soria","year":"2018","unstructured":"Soria J-C, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, et\u00a0al. Osimertinib in untreated EGFR -mutated advanced non\u2013small-cell lung cancer. N Engl J Med. 2018. https:\/\/doi.org\/10.1056\/NEJMoa1713137.","journal-title":"N Engl J Med"},{"key":"930_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, et\u00a0al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med. 2020;382:41\u201350. https:\/\/doi.org\/10.1056\/NEJMoa1913662.","journal-title":"N Engl J Med"},{"key":"930_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11912-025-01655-5","volume":"27","author":"RK Tawfiq","year":"2025","unstructured":"Tawfiq RK, de Camargo Correia GS, Li S, Zhao Y, Lou Y, Manochakian R. Targeting lung cancer with precision: the ADC therapeutic revolution. Curr Oncol Rep. 2025;27:669\u201386. https:\/\/doi.org\/10.1007\/s11912-025-01655-5.","journal-title":"Curr Oncol Rep"},{"key":"930_CR45","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.apsb.2024.02.003","volume":"14","author":"C Qian","year":"2024","unstructured":"Qian C, Zhou Y, Zhang T, Dong G, Song M, Tang Y, et\u00a0al. Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery. Acta Pharm Sin B. 2024;14:2077\u201396. https:\/\/doi.org\/10.1016\/j.apsb.2024.02.003.","journal-title":"Acta Pharm Sin B"},{"key":"930_CR46","doi-asserted-by":"publisher","first-page":"115166","DOI":"10.1016\/j.ejmech.2023.115166","volume":"249","author":"H Lin","year":"2023","unstructured":"Lin H, Han H, Yang M, Wen Z, Chen Q, Ma Y, et\u00a0al. PKM2\/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism. Eur J Med Chem. 2023;249:115166. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115166.","journal-title":"Eur J Med Chem"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00930-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00930-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00930-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:02:59Z","timestamp":1783951379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00930-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00930-y","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Local Ethics Committee of Qingdao University on 25 September 2024 and 13 December 2025 (Approval No. 20241001BALB\/cNu1220241115083 and 20251214BALB\/C-nude20260214049). The committee acts in accordance with the guidelines of the International Council for Laboratory Animal Science (ICLAS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}